Explore the full record of transactions filed by Seeley Bruce J., Directeur Exécutif et COO. Insider active across 1 company, notably CTI Biopharma CORP. In total, 1 filings have been logged. Activity tracked since 30 June 2021. The latest transaction was disclosed on 30 June 2021 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Bruce J. Seeley is the Executive Vice President and COO of CTI Biopharma Corp. He is responsible for managing the company's operations and optimizing processes. With significant experience in the biopharmaceutical sector, he plays a key role in improving operational efficiency and product quality. His expertise contributes to the competitive position of CTI Biopharma Corp.